|
|
|
Insider
Information: |
Mario Ernest |
Relationship: |
Director |
City: |
Redwood City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
13 |
|
Direct
Shares |
1,151,697 |
|
Indirect Shares
|
265,510 |
|
|
Direct
Value |
$8,534,238 |
|
|
Indirect Value
|
$109,674 |
|
|
Total
Shares |
1,417,207 |
|
|
Total
Value |
$8,643,912 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
3
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-41.7%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Maxygen Inc |
MAXY |
Director |
2012-06-06 |
62,964 |
2003-08-05 |
0 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director |
2004-05-05 |
70,431 |
2004-05-05 |
85,554 |
Premium* |
|
Pharmaceutical Product Developme... |
PPDI |
Director |
2011-12-05 |
0 |
2011-12-05 |
0 |
Premium* |
|
Boston Scientific Corp |
BSX |
Director |
2015-11-16 |
86,032 |
2013-11-08 |
0 |
Premium* |
|
Alexza Pharmaceuticals Inc. |
ALXA |
Director |
2006-03-08 |
18,181 |
|
0 |
Premium* |
|
Celgene Corp |
CELG |
|
2019-11-20 |
0 |
2019-11-20 |
0 |
Premium* |
|
Vivus Inc |
VVUS |
Director |
2013-05-29 |
81,125 |
2012-04-25 |
0 |
Premium* |
|
Xenoport Inc |
XNPT |
Director |
2015-05-19 |
88,750 |
2012-08-09 |
0 |
Premium* |
|
Tonix Pharmaceuticals Holding Corp |
TNXP |
Director |
2018-02-09 |
0 |
2018-06-25 |
50,000 |
Premium* |
|
Chimerix Inc |
CMRX |
Director |
2018-05-18 |
12,905 |
2018-05-18 |
108,167 |
Premium* |
|
Kindred Biosciences, Inc. |
KIN |
Director |
2018-10-29 |
169,000 |
2013-12-12 |
0 |
Premium* |
|
Soleno Therapeutics Inc |
SLNO |
|
2024-05-21 |
186,566 |
2024-05-21 |
21,789 |
Premium* |
|
Eyenovia Inc |
EYEN |
Director |
2021-01-15 |
375,743 |
2018-07-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
373 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 15
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CELG |
Celgene Corp |
|
|
2019-01-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,100 |
57,913 |
0 |
- |
|
CELG |
Celgene Corp |
|
|
2019-06-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
484 |
62,209 |
0 |
- |
|
CELG |
Celgene Corp |
|
|
2019-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
300 |
62,509 |
0 |
- |
|
CELG |
Celgene Corp |
|
|
2019-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
375 |
62,884 |
0 |
- |
|
EYEN |
Eyenovia Inc |
Director |
|
2019-08-16 |
4 |
A |
$0.00 |
$0 |
D/D |
8,038 |
280,779 |
0 |
- |
|
CELG |
Celgene Corp |
|
|
2019-11-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(62,884) |
0 |
0 |
- |
|
CELG |
Celgene Corp |
|
|
2019-11-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(4,908) |
0 |
0 |
- |
|
EYEN |
Eyenovia Inc |
Director |
|
2020-09-11 |
4 |
A |
$0.00 |
$0 |
D/D |
7,288 |
334,527 |
0 |
- |
|
SLNO |
Soleno Therapeutics Inc |
Director |
|
2021-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
8,928 |
1,157,804 |
0 |
- |
|
SLNO |
Soleno Therapeutics Inc |
Director |
|
2021-10-29 |
4 |
A |
$0.00 |
$0 |
D/D |
26,888 |
1,376,797 |
0 |
- |
|
SLNO |
Soleno Therapeutics Inc |
Director |
|
2022-03-31 |
4 |
B |
$0.00 |
$0 |
D/D |
930,000 |
2,363,135 |
2.31 |
% |
|
SLNO |
Soleno Therapeutics Inc |
Director |
|
2022-03-31 |
4 |
B |
$0.00 |
$0 |
I/I |
930,000 |
930,000 |
2.02 |
% |
|
SLNO |
Soleno Therapeutics Inc |
Director |
|
2023-11-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
8,700 |
128,089 |
0 |
- |
|
SLNO |
Soleno Therapeutics Inc |
Director |
|
2024-01-08 |
4 |
GD |
$0.00 |
$0 |
D/D |
3,523 |
124,566 |
0 |
- |
|
KIN |
Kindred Biosciences, Inc. |
Director |
|
2014-02-05 |
4 |
OE |
$0.32 |
$4,000 |
D/D |
12,500 |
37,500 |
0 |
- |
|
KIN |
Kindred Biosciences, Inc. |
Director |
|
2014-05-09 |
4 |
OE |
$0.32 |
$800 |
D/D |
2,500 |
40,000 |
0 |
- |
|
KIN |
Kindred Biosciences, Inc. |
Director |
|
2014-08-01 |
4 |
OE |
$0.32 |
$800 |
D/D |
2,500 |
42,500 |
0 |
- |
|
KIN |
Kindred Biosciences, Inc. |
Director |
|
2015-06-02 |
4 |
OE |
$0.32 |
$14,654 |
D/D |
17,083 |
69,583 |
0 |
- |
|
SLNO |
Soleno Therapeutics Inc |
Director |
|
2022-01-31 |
4 |
A |
$0.36 |
$20,000 |
D/D |
56,338 |
1,433,135 |
0 |
- |
|
TNXP |
Tonix Pharmaceuticals Hol... |
Director |
|
2013-04-26 |
4 |
OE |
$0.40 |
$66,667 |
D/D |
166,667 |
1,447,079 |
0 |
- |
|
TNXP |
Tonix Pharmaceuticals Hol... |
Director |
|
2016-11-23 |
4 |
B |
$0.41 |
$48,600 |
I/I |
120,000 |
120,000 |
2.1 |
- |
|
SLNO |
Soleno Therapeutics Inc |
Director |
|
2017-10-02 |
4 |
A |
$0.52 |
$15,000 |
D/D |
28,846 |
1,873,174 |
0 |
- |
|
SLNO |
Soleno Therapeutics Inc |
Director |
|
2017-07-16 |
4 |
A |
$0.61 |
$15,000 |
D/D |
24,590 |
1,844,328 |
0 |
- |
|
SLNO |
Soleno Therapeutics Inc |
Director |
|
2017-04-07 |
4 |
A |
$0.63 |
$15,000 |
D/D |
23,809 |
1,819,738 |
0 |
- |
|
TNXP |
Tonix Pharmaceuticals Hol... |
Director |
|
2016-09-13 |
4 |
B |
$0.79 |
$79,180 |
D/D |
100,000 |
530,724 |
2.39 |
- |
|
373 Records found
|
|
Page 6 of 15 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|